Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients. (Q50574716)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Jose A Muñoz-Moreno

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Daniel Fuster

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Núria Pérez-Álvarez

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Bonaventura Clotet Sala

12

object named as

B Clotet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

C R Fumaz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

A L Ballesteros

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

R Paredes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

M J Ferrer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

A Salas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

E Masmitjà

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

C Tural

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

138-145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17129869%20AND%20SRC:MED&resulttype=core&format=json

Reduced quality of life in patients with chronic hepatitis C: effects of interferon treatment.

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

The prevalence of distress in persons with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

Comparison of WHOQOL-bREF and SF-36 in patients with HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

The drugs or the disease? Causal attributions of symptoms held by HIV-positive adults on HAART

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

Paroxetine for the prevention of depression induced by high-dose interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

Physiological and psychological correlates of fatigue in HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

Side effects of therapy for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120600645539